The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis

Advances in Experimental Medicine and Biology

Volumn 649, Issue , 2009, Pages 277-285

  Kollnberger, Simon ^a   Bowness, Paul ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; GAMMA INTERFERON; HLA B27 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PAIRED IMMUNOGLOBULIN LIKE RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; ANTIGEN FUNCTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL SURFACE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HEAVY CHAIN; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LEUKOCYTE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NATURAL KILLER T CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN STRUCTURE; SPONDYLOSIS; TRANSGENIC RAT; UPREGULATION; WESTERN BLOTTING; CHEMISTRY; DIMERIZATION; GENETICS; IMMUNOLOGY; NATURAL KILLER CELL; PROTEIN CONFORMATION; REVIEW; SPONDYLARTHRITIS; T LYMPHOCYTE;

RODENTIA;

DIMERIZATION; HLA-B27 ANTIGEN; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES; PROTEIN CONFORMATION; RECEPTORS, IMMUNOLOGIC; SPONDYLARTHRITIS; T-LYMPHOCYTES;

EID: 70349568505     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0298-6_21     Document Type: Article

References (39)

1. Brown MA, Pile KD. Kennedy LG et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Annals Rheum Dis 1996; 55:268-270. (Pubitemid 26120706)
2. Allen RL, Bowness P. McMichael A. The role of HLA-B27 in spondyloarthritis. Immunogenetics 1999; 50:220-227. (Pubitemid 30099527)
3. Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: Pathogenetic and clinical considerations. Clin Microbiol Rev 2004; 17(2) :348-69. Review. (Pubitemid 38534032)
4. May E, Dorris ML, Saturntira N et al. CD8 αβ T-cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol 2003; 170(2):1099-105. (Pubitemid 36070566)
5. Allen RL, O'Callaghan CA, McMichael AJ et al. 1999. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol 162:5045-5048. (Pubitemid 29307101)
6. Starn NJ, Vroom TM, Peters PJ et al. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-imrnuno-electron microscopy. Int Immunol 1990; 2(2):113-25. (Pubitemid 20050409)
7. Raine T, Brown D, Bowness P et al. Consistent patterns of expression of HLA class I free heavy chains in healthy individuals and raised expression in spondyloarrhropachy patients point to physiological and pathological roles. Rheumatology (Oxford) 2006; 45(11):1338-44. (Pubitemid 44605466)
8. Tsai WC, Chen CJ, Yen J et al. Free HLA class I heavy chain-carrying monocytes - A potential role in the pathogenesis of spondyloarrhropathies, J Rheumatol 2002; 29:966-972. (Pubitemid 34493502)
9. Lan CC, Tsai WC, Wu CS et al. Psoriatic patients with arthropathy show significant expression of free HLA class I heavy chains on circulating monocytes: A potential role in the pathogenesis of psoriatic arthropathy. Br J Derrnarol 2004; 151(1):24-31. (Pubitemid 39061277)
10. Kollnberger S, Bird L, Sun MY et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002; 46(11):2972-82. (Pubitemid 35315891)
11. Bird LA, Peh CA, Kollnberger S et al. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol 2003; 33:748-759. (Pubitemid 36367678)
12. Kollnberger S, Bird LA, Roddis M et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 2004; 173(3):1699-710. (Pubitemid 38971601)
13. Kollnberger S, Chan A, Sun MY et al. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterocrimers, is independent of the sequence of bound peptide. Eur J Immunol 2007; 37(5):1313-22. (Pubitemid 46925315)
14. Zhou M, Sayad A, Simmons WA et al. The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. J Exp Med 1998; 188(5):877-86. (Pubitemid 28433414)
15. Tran TM, Dorris ML, Satumtira N et al. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum 2006; 54(4):1317-27. (Pubitemid 43672945)
16. Boyson JE, Erskine R, Whitman MC et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci USA. 2002; 99(25):16180-5. (Pubitemid 35462769)
17. Apps R, Gardner L, Sharkey AM et al. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRBI. Eur J Immunol 2007; 37(7):1924-37. (Pubitemid 47065129)
18. Lanier LL, Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 1998; 92:705-707. (Pubitemid 28155309)
19. Colonna M, Nakajima H, Navarro F et al. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Bioi 1999; 66(3):375-81. Review. (Pubitemid 29439243)
20. Takai T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005; 115(4):433-40. Review. (Pubitemid 41032431)
21. Diefenbach A, Raulet DH. Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 2003; 15(1):37-44. Review. (Pubitemid 35454190)
22. Vankayalapati R, Wizel B, Weis SE et al. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2002; 168(7):3451-7. (Pubitemid 34250410)
23. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20:217-51. (Pubitemid 34293425)
24. Yokoyama WM, Kim S. How do natural killer cells find self to achieve tolerance? Immunity 2006; 24(3):249-57. Review.
25. Goronzy JJ, Henel G, Sawai H et al. Costirnulatory pathways in rheumatoid synovitis and T-cell senescence. Ann NY Acad Sci 2005; 1062:182-94. Review.
26. Young NT, Uhrberg M. KIR expression shapes cytotoxic repertoires: a developmental program of survival. Trends Immunol 2002; 23(2):71-5. Review. (Pubitemid 34310147)
27. Van Bergen J, Thompson A, van der Slik A et al. Phenotypic and functional characterization of CD4 T-cells expressing killer Ig-like receptors. J Immunol 2004; 173(11) :6719-26. (Pubitemid 39541057)
28. Abedin S. Michel JJ, Lernster B ec al. Diversity of NKR expression in aging T-cells and in T-cells of the aged: the new frontier into the exploration of protective immunity in the elderly. Mech Ageing Dev 2005; 126(6-7):722-31.
29. Ugolini S, Arpin C, Anfossi N et al. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T-cells. Nat Immunol 2001; 2:430-435. (Pubitemid 33706141)
30. Nelson GW, Martin MP, Gladman D et al. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004; 173(7):4273-6. (Pubitemid 39280654)
31. Ristich V, Liang S, Zhang W et al. Tolerization of dendritic cells by HLA-G. Eur] Immunol 2005; 35(4):1133-42. (Pubitemid 40542220)
32. Chang CC, Ciubotariu R, Manavalan JS et al. Tolerizarion of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002; 3(3) :215-7.
33. Allen RL, Raine T, Haude A et al. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol 2001; 167(10):5543-7. (Pubitemid 33062742)
34. Horuzsko A, Lenfant F, Munn DH et al. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 2001; 13(3):385-94. (Pubitemid 32179087)
35. Ujike A, Takeda K, Nakamura A et al. Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. Nat Immunol 2002; 3(6):542-8. (Pubitemid 34662306)
36. Hacquard-Bouder C, Falgarone G, Bosquet A et al. Defective costimularor y function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthroparhy, Arthritis Rheum 2004; 50(5):1624-35. (Pubitemid 38608085)
37. Liu J, Liu Z, Witkowski P et al. Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the gratt invulne rable to rejection. Transpl Immunol 2004; 13(4):239-47. (Pubitemid 39602590)
38. Chan AT, Kollnberger SD, Wedderburn LR et al. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spond ylarthritis. Arthritis Rheum 2005; 52(11):3586-95. (Pubitemid 41612228)
39. Dufiner C, Goldberger C, Falkenbach A et al. Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T-cells in ankylosing spondylitis. Arthritis Res Ther 2003; 5(5):R292-300.